Top compounds associated with response to MED22


Feature Type Standardized
Nominal ANOVA
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.09 0.003
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.091 0.004
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.15 0.004
mRNA PI-103 GDSC1000 pan-cancer AAC 0.085 0.004
mRNA manumycin A CTRPv2 pan-cancer AAC 0.09 0.005
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.095 0.005
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.085 0.005
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.082 0.005
mRNA RO-3306 GDSC1000 pan-cancer AAC -0.095 0.005
mRNA B02 CTRPv2 pan-cancer AAC 0.1 0.005
Download CSV